ANTI-MTBP (IN2) Chemische Eigenschaften,Einsatz,Produktion Methoden

Biochem/physiol Actions

The gene MTBP (Mdm2-binding protein) is mapped to human chromosome 8q24. It is involved in the development and progression of cancer. In hepatocellular carcinoma, MTBP enhances MDM2 (E3 ubiquitin-protein ligase)-associated degradation of E-cadherin. It is also suggested as a therapeutic target for treatment of triple-negative breast cancer. MTBP is a transcriptional target of Myc. It plays an important role in cell cycle progression. Silencing of this gene causes delay in cell cycle progress at S and G2/M phases.

ANTI-MTBP (IN2) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

ANTI-MTBP (IN2) Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Riedel-de Haen AG	--		United States	6773	87
SIGMA-RBI	--		Switzerland	6896	91
EMD Biosciences, Inc.	--	technical@calbiochem.com	United States	6529	66

---

• ANTI-MTBP (122-139) RABBIT PAB
• ANTI-MTBP, HUMAN
• ANTI-MTBP (IN2)
• ANTI-MTBP, INTERMEDIATE DOMAIN 2
• ANTI-MDM2 BINDING PROTEIN (122-139) RABBIT PAB
• ANTI-MDM2 BINDING PROTEIN, HUMAN
• ANTI-MDM2 (TWO)-BINDING PROTEIN
• Anti-MDM2-Binding Protein
• Anti-MTBP, Intermediate Domain 2 antibody produced in rabbit
• Anti-Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa
• Anti-hMTBP
• Anti-MTBP antibody produced in rabbit